Effect of Rosa canina on non alcoholic fatty liver
- Conditions
- on alcoholic fatty liver(NAFLD).Fatty (change of) liver, not elsewhere classified
- Registration Number
- IRCT2017011514333N65
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 70
Diagnosis of non-alcoholic fatty diseases based on AST and ALT level more than 30 in men and 20 in women and also liver ultrasound; Aged between 30-65 years; BMI greater than 25;
Non-use of antioxidant supplements during one month prior to sampling; Non-acute cardiac disease, renal, infectious, diabetes, hepatitis B or C and other liver diseases; Not being on an intense increasing or decreasing diet weight during the last three months prior to sampling; lack of effective drugs on weight during the last three months prior to sampling; not using medications that may be associated with the disease (methotrexate, amiodarone, tamoxifen, corticosteroids, valproic acid).
Exclusion criteria: Not wanting to continue the study; Use of drugs that affect the liver; The risk of diseases that require special treatment; pregnancy during the study.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver enzymes. Timepoint: Baseline, 48 hours after the end of the study (study will take 8 weeks). Method of measurement: Based on the results of blood tests (including ALT and AST).
- Secondary Outcome Measures
Name Time Method